Medical cannabis products are legal in the UK from today – in very limited circumstances. This could include products without marketing authorisation, if approved by a registered specialist in certain conditions.
A change in the law brought about in a few short months enables cannabis-based products for medicinal use in humans to be prescribed as a Schedule 2 drug – essentially drugs that can be legally prescribed but carry higher risks for potential abuse.
This could be a special medicinal product for use at the direction of a doctor on the General Medical Council’s specialist register; an investigational medicinal product without marketing authorisation for use in a clinical trial; or a medicinal product with a marketing authorisation.
Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.